These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2384505)

  • 21. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacitracin treatment of antibiotic-associated colitis and diarrhea caused by Clostridium difficile toxin.
    Chang TW; Gorbach SL; Bartlett JG; Saginur R
    Gastroenterology; 1980 Jun; 78(6):1584-6. PubMed ID: 7372074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.
    Viscidi R; Willey S; Bartlett JG
    Gastroenterology; 1981 Jul; 81(1):5-9. PubMed ID: 7239125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium difficile infection frequency in patients with nosocomial infections or using antibiotics.
    Gursoy S; Guven K; Arikan T; Yurci A; Torun E; Baskol M; Ozbakir O; Yucesoy M
    Hepatogastroenterology; 2007 Sep; 54(78):1720-4. PubMed ID: 18019703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Harnedy N; Fanning S; Hannan M; Kyne L
    Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile.
    Bishara J; Peled N; Pitlik S; Samra Z
    J Hosp Infect; 2008 Apr; 68(4):308-14. PubMed ID: 18353491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium difficile infection.
    Kelly CP; LaMont JT
    Annu Rev Med; 1998; 49():375-90. PubMed ID: 9509270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridium difficile: epidemiology and clinical features.
    Marrie TJ; Furlong M; Faulkner RS; Sidorov J; Haldane EV; Kerr EA
    Can J Surg; 1982 Jul; 25(4):438-42. PubMed ID: 7093841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of Clostridium difficile infection in children with inflammatory bowel disease compared to oncology and immunocompetent patients.
    Hojsak I; Ferenc T; Bojanić K; Mišak Z; Močić Pavić A; Lukić-Grlić A; Kolaček S
    Digestion; 2012; 86(1):6-11. PubMed ID: 22688504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina].
    Fernandez Canigia L; Nazar J; Arce M; Dadamio J; Smayevsky J; Bianchini H
    Rev Argent Microbiol; 2001; 33(2):101-7. PubMed ID: 11494752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental studies of antibiotic associated colitis.
    Bartlett JG
    Scand J Infect Dis Suppl; 1980; (Suppl 22):11-5. PubMed ID: 6937944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea.
    O'Connor D; Hynes P; Cormican M; Collins E; Corbett-Feeney G; Cassidy M
    J Clin Microbiol; 2001 Aug; 39(8):2846-9. PubMed ID: 11474001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Faecal toxin and severity of antibiotic-associated pseudomembranous colitis.
    Burdon DW; George RH; Mogg GA; Arabi Y; Thompson H; Johnson M; Alexander-Williams J; Keighley MR
    J Clin Pathol; 1981 May; 34(5):548-51. PubMed ID: 7251895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates.
    Akerlund T; Svenungsson B; Lagergren A; Burman LG
    J Clin Microbiol; 2006 Feb; 44(2):353-8. PubMed ID: 16455883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Clostridium difficile-associated diarrhea among patients hospitalized in tertiary care academic hospital.
    Martirosian G; Szczesny A; Cohen SH; Silva J
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):153-5. PubMed ID: 15964504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ["Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy].
    Sednaoui P; el Mantih B; Cauwell M
    Pathol Biol (Paris); 1999 May; 47(5):415-21. PubMed ID: 10418011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.
    De Barbeyrac B; Guinet R; Quentin C; Cantet P; Bebear C
    Ann Biol Clin (Paris); 1989; 47(2):67-70. PubMed ID: 2660635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic-associated pseudomembranous colitis.
    Amin NM
    Am Fam Physician; 1985 May; 31(5):115-20. PubMed ID: 3993509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea.
    Heimesaat MM; Granzow K; Leidinger H; Liesenfeld O
    Infection; 2005 Oct; 33(5-6):340-4. PubMed ID: 16258864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing incidence and clinical manifestations of Clostridium difficile-associated diarrhea detected by combination of glutamate dehydrogenase and toxin assay in Northern Taiwan.
    Lee YC; Wang JT; Chen AC; Sheng WH; Chang SC; Chen YC
    J Microbiol Immunol Infect; 2012 Aug; 45(4):287-95. PubMed ID: 22209696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.